Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Quinn A. Vatland
A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Rhein Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells With MEK/ERK Signaling Pathway Inhibitors
PLoS ONE
Multidisciplinary
CCL21/CCR7 Prevents Apoptosis via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells
PLoS ONE
Multidisciplinary
A YWHAZ Variant Associated With Cardiofaciocutaneous Syndrome Activates the RAF-ERK Pathway
Frontiers in Physiology
Physiology
A Nuclear-Directed Human Pancreatic Ribonuclease (PE5) Targets the Metabolic Phenotype of Cancer Cells
Oncotarget
Oncology
P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Using a Doe and Eis to Evaluate the Synergistic Effects of Low Toxicity Inhibitors for Mild Steel
Brazilian Journal of Chemical Engineering
Chemical Engineering
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
PLoS ONE
Multidisciplinary
APOL1 Variant-Expressing Endothelial Cells Exhibit Autophagic Dysfunction and Mitochondrial Stress
